Interstitial lung disease in systemic sclerosis: An HRCT-clinical correlative study

Purpose: To evaluate high-resolution CT (HRCT) parameters of inflammation and fibrosis in systemic sclerosis (SSc), for correlation with lung function, skin scores and exercise tolerance. Material and Methods: 45 SSc patients (40 women, 48.5±13.4 years), underwent thoracic HRCT, lung function assessment, and modified Rodnan skin scores. Exercise tolerance was also graded. HRCT were scored for extent of 4 HRCT patterns of interstitial lung disease (ILD): ground glass opacification (GGO), reticular, mixed and honeycomb pattern in each lobe. Total HRCT score, inflammation index (GGO and mixed score) and fibrosis index (reticular and honeycomb scores) were correlated with lung function and clinical parameters. Results: ILD was present in 39/45 (86.7%) patients. Abnormal (<80% predicted) forced vital capacity (FVC), total lung capacity (TLC) and carbon monoxide diffusion factor (DLco) were detected in 30%, 22% and 46% of patients. Total HRCT score correlated with FVC (r=−0.43, p=0.008), FEV1 (forced expiratory volume) (r=–0.37, p=0.03), TLC (r=–0.47, p=0.003), and DLCO (r=–0.43, p=0.008); inflammatory index with DLCO (r=–0.43, p=0.008) and exercise tolerance (r=–0.39, p < 0.05); and fibrosis index with FVC (r=–0.31, p=0.05) and TLC (r=–0.38, p=0.02). Higher total HRCT score, and inflammation and fibrosis indices were found in patients with abnormal lung function. Conclusion: Qualitative HRCT is able to evaluate inflammation and fibrosis, showing important relationships with diffusion capacity and lung volume, respectively.

[1]  A. Silman,et al.  Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. , 1993, The Journal of rheumatology.

[2]  M. Guttadauria,et al.  Pulmonary function in scleroderma. , 1977, Arthritis and rheumatism.

[3]  H. Itoh,et al.  Usual interstitial pneumonia: histologic correlation with high-resolution CT. , 1992, Radiology.

[4]  J. Remy,et al.  Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. , 1993, Radiology.

[5]  G. Ooi,et al.  Systemic lupus erythematosus patients with respiratory symptoms: the value of HRCT. , 1997, Clinical radiology.

[6]  M. A. Hamid,et al.  Pulmonary function tests, high-resolution computerized tomography, α1-antitrypsin measurement, and early detection of pulmonary involvement in patients with systemic sclerosis , 2001, Rheumatology International.

[7]  A. Masi Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[8]  D. Hughes,et al.  Serial pulmonary function tests in progressive systemic sclerosis. , 1979, Thorax.

[9]  M. Thomson,et al.  The effect of age, body size and lung volume change on alveolar‐capillary permeability and diffusing capacity in man , 1959, The Journal of physiology.

[10]  E. Effmann,et al.  Systemic sclerosis: using high-resolution CT to detect lung disease in children. , 1998, AJR. American journal of roentgenology.

[11]  B. Corrin,et al.  Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance. , 1989, Respiratory medicine.

[12]  F. Baragar,et al.  The lungs in systemic sclerosis (scleroderma): a review and new information. , 1988, Seminars in arthritis and rheumatism.

[13]  A. Weaver,et al.  Clinical InvestigationsPulmonary Scleroderma , 1968 .

[14]  J. Im,et al.  Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT. , 1992, Radiology.

[15]  N. Müller,et al.  Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. , 1987, Radiology.

[16]  N L Müller,et al.  Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26 patients. , 1992, Radiology.

[17]  T. Geppert Southwestern Internal Medicine Conference: Clinical Features, Pathogenic Mechanisms, and New Developments in the Treatment of Systemic Sclerosis , 1990 .

[18]  D. Hansell,et al.  The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. , 1993, The American review of respiratory disease.

[19]  R. Rogers,et al.  Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma. , 1983, Chest.

[20]  D. Hansell,et al.  High resolution computed tomography as a predictor of lung histology in systemic sclerosis. , 1992, Thorax.

[21]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[22]  S. Schabel,et al.  High resolution computed tomography in early scleroderma lung disease. , 1991, The Journal of rheumatology.

[23]  D. Postma,et al.  Bronchoalveolar lavage cell analysis and lung function impairment in patients with systemic lupus erythematosus (SLE) , 1993, Clinical and experimental immunology.

[24]  D M Hansell,et al.  Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. , 1993, AJR. American journal of roentgenology.